220 related articles for article (PubMed ID: 30328647)
1. The Effects of Noninvasive Vagus Nerve Stimulation on Fatigue and Immune Responses in Patients With Primary Sjögren's Syndrome.
Tarn J; Legg S; Mitchell S; Simon B; Ng WF
Neuromodulation; 2019 Jul; 22(5):580-585. PubMed ID: 30328647
[TBL] [Abstract][Full Text] [Related]
2. The Effects of Noninvasive Vagus Nerve Stimulation on Fatigue in Participants With Primary Sjögren's Syndrome.
Tarn J; Evans E; Traianos E; Collins A; Stylianou M; Parikh J; Bai Y; Guan Y; Frith J; Lendrem D; Macrae V; McKinnon I; Simon BS; Blake J; Baker MR; Taylor JP; Watson S; Gallagher P; Blamire A; Newton J; Ng WF
Neuromodulation; 2023 Apr; 26(3):681-689. PubMed ID: 37032583
[TBL] [Abstract][Full Text] [Related]
3. Noninvasive Transcutaneous Vagus Nerve Stimulation Decreases Whole Blood Culture-Derived Cytokines and Chemokines: A Randomized, Blinded, Healthy Control Pilot Trial.
Lerman I; Hauger R; Sorkin L; Proudfoot J; Davis B; Huang A; Lam K; Simon B; Baker DG
Neuromodulation; 2016 Apr; 19(3):283-90. PubMed ID: 26990318
[TBL] [Abstract][Full Text] [Related]
4. Fatigue in primary Sjögren's syndrome (pSS) is associated with lower levels of proinflammatory cytokines: a validation study.
Davies K; Mirza K; Tarn J; Howard-Tripp N; Bowman SJ; Lendrem D; ; Ng WF
Rheumatol Int; 2019 Nov; 39(11):1867-1873. PubMed ID: 31250166
[TBL] [Abstract][Full Text] [Related]
5. Understanding Fatigue in Sjögren's Syndrome: Outcome Measures, Biomarkers and Possible Interventions.
Mæland E; Miyamoto ST; Hammenfors D; Valim V; Jonsson MV
Front Immunol; 2021; 12():703079. PubMed ID: 34249008
[TBL] [Abstract][Full Text] [Related]
6. Treatment of primary Sjögren's syndrome with ianalumab (VAY736) targeting B cells by BAFF receptor blockade coupled with enhanced, antibody-dependent cellular cytotoxicity.
Dörner T; Posch MG; Li Y; Petricoul O; Cabanski M; Milojevic JM; Kamphausen E; Valentin MA; Simonett C; Mooney L; Hüser A; Gram H; Wagner FD; Oliver SJ
Ann Rheum Dis; 2019 May; 78(5):641-647. PubMed ID: 30826774
[TBL] [Abstract][Full Text] [Related]
7. Diminished cellular immune response to carbonic anhydrase II in patients with Sjögren's syndrome and idiopathic chronic pancreatitis.
Nishimori I; Miyaji E; Morimoto K; Kohsaki T; Okamoto N; Onishi S
JOP; 2004 Jul; 5(4):186-92. PubMed ID: 15254347
[TBL] [Abstract][Full Text] [Related]
8. Transcutaneous auricular vagus nerve stimulation reduces pain and fatigue in patients with systemic lupus erythematosus: a randomised, double-blind, sham-controlled pilot trial.
Aranow C; Atish-Fregoso Y; Lesser M; Mackay M; Anderson E; Chavan S; Zanos TP; Datta-Chaudhuri T; Bouton C; Tracey KJ; Diamond B
Ann Rheum Dis; 2021 Feb; 80(2):203-208. PubMed ID: 33144299
[TBL] [Abstract][Full Text] [Related]
9. Acupuncture for Primary Sjögren Syndrome (pSS) on symptomatic improvements: study protocol for a randomized controlled trial.
Jiang Q; Zhang H; Pang R; Chen J; Liu Z; Zhou X
BMC Complement Altern Med; 2017 Jan; 17(1):61. PubMed ID: 28103850
[TBL] [Abstract][Full Text] [Related]
10. Transcranial direct current stimulation for fatigue in patients with Sjogren's syndrome: A randomized, double-blind pilot study.
Pinto ACPN; Piva SR; Vieira AGDS; Gomes SGCN; Rocha AP; Tavares DRB; Santana MVA; Carlesso C; Andriolo A; Santos FC; Fregni F; Trevisani VFM
Brain Stimul; 2021; 14(1):141-151. PubMed ID: 33340767
[TBL] [Abstract][Full Text] [Related]
11. Serological lymphocytic activity and patient-reported outcomes in Sjögren's syndrome.
Jülich M; Kanne AM; Sehnert B; Budweiser S; Voll RE; Kollert F
Clin Rheumatol; 2018 Sep; 37(9):2361-2366. PubMed ID: 29858711
[TBL] [Abstract][Full Text] [Related]
12. Expression of interleukin-17 in primary Sjögren's syndrome and the correlation with disease severity: A systematic review and meta-analysis.
Zhang LW; Zhou PR; Wei P; Cong X; Wu LL; Hua H
Scand J Immunol; 2018 Apr; 87(4):e12649. PubMed ID: 29476557
[TBL] [Abstract][Full Text] [Related]
13. Natural killer cell activity in Sjögren's syndrome and systemic lupus erythematosus: stimulation with interferons and interleukin-2 and correlation with immune complexes.
Struyf NJ; Snoeck HW; Bridts CH; De Clerck LS; Stevens WJ
Ann Rheum Dis; 1990 Sep; 49(9):690-3. PubMed ID: 1700674
[TBL] [Abstract][Full Text] [Related]
14. In vitro suppression of immune responses using monocyte-derived tolerogenic dendritic cells from patients with primary Sjögren's syndrome.
Volchenkov R; Brun JG; Jonsson R; Appel S
Arthritis Res Ther; 2013; 15(5):R114. PubMed ID: 24025795
[TBL] [Abstract][Full Text] [Related]
15. Brain-derived neurotrophic factor and nerve growth factor correlate with T-cell activation in primary Sjogren's syndrome.
Fauchais AL; Boumediene A; Lalloue F; Gondran G; Loustaud-Ratti V; Vidal E; Jauberteau MO
Scand J Rheumatol; 2009; 38(1):50-7. PubMed ID: 18830907
[TBL] [Abstract][Full Text] [Related]
16. Elevated cytokine levels in tears and saliva of patients with primary Sjögren's syndrome correlate with clinical ocular and oral manifestations.
Chen X; Aqrawi LA; Utheim TP; Tashbayev B; Utheim ØA; Reppe S; Hove LH; Herlofson BB; Singh PB; Palm Ø; Galtung HK; Jensen JCL
Sci Rep; 2019 May; 9(1):7319. PubMed ID: 31086200
[TBL] [Abstract][Full Text] [Related]
17. Alteration of CD226/TIGIT immune checkpoint on T cells in the pathogenesis of primary Sjögren's syndrome.
Deng C; Chen Y; Li W; Peng L; Luo X; Peng Y; Zhao L; Wu Q; Zhang W; Zhang X; Fei Y
J Autoimmun; 2020 Sep; 113():102485. PubMed ID: 32466852
[TBL] [Abstract][Full Text] [Related]
18. The effects of resistance training in patients with primary Sjogren's syndrome.
Dardin LP; Garcia ABA; Minali PA; Pinto ACPN; Trevisani VFM
Clin Rheumatol; 2022 Apr; 41(4):1145-1152. PubMed ID: 34748096
[TBL] [Abstract][Full Text] [Related]
19. B-cell activating factor of the tumour necrosis factor family expression in blood monocytes and T cells from patients with primary Sjögren's syndrome.
Lavie F; Miceli-Richard C; Ittah M; Sellam J; Gottenberg JE; Mariette X
Scand J Immunol; 2008 Feb; 67(2):185-92. PubMed ID: 18201372
[TBL] [Abstract][Full Text] [Related]
20. A five-year prospective study of fatigue in primary Sjögren's syndrome.
Haldorsen K; Bjelland I; Bolstad AI; Jonsson R; Brun JG
Arthritis Res Ther; 2011; 13(5):R167. PubMed ID: 21996338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
